Regeneron Pharmaceuticals, Inc. (REGN)
USD 556.81
(-2.79%)
USD 556.81
(-2.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.3 Billion USD | 6.49% |
| 2022 | 10.61 Billion USD | -22.16% |
| 2021 | 13.63 Billion USD | 84.82% |
| 2020 | 7.37 Billion USD | 4.18% |
| 2019 | 7.08 Billion USD | 12.82% |
| 2018 | 6.27 Billion USD | 14.64% |
| 2017 | 5.47 Billion USD | 20.05% |
| 2016 | 4.56 Billion USD | 22.9% |
| 2015 | 3.71 Billion USD | 41.94% |
| 2014 | 2.61 Billion USD | 34.12% |
| 2013 | 1.94 Billion USD | 50.65% |
| 2012 | 1.29 Billion USD | 193.03% |
| 2011 | 441.6 Million USD | -3.36% |
| 2010 | 456.98 Million USD | 21.03% |
| 2009 | 377.58 Million USD | 58.96% |
| 2008 | 237.53 Million USD | 89.99% |
| 2007 | 125.02 Million USD | 126.08% |
| 2006 | 55.3 Million USD | -2.36% |
| 2005 | 56.63 Million USD | -64.34% |
| 2004 | 158.8 Million USD | 212.48% |
| 2003 | 50.82 Million USD | 227.77% |
| 2002 | 15.5 Million USD | 0.27% |
| 2001 | 15.46 Million USD | -64.62% |
| 2000 | 43.71 Million USD | 41.46% |
| 1999 | 30.9 Million USD | -6.93% |
| 1998 | 33.2 Million USD | 8.85% |
| 1997 | 30.5 Million USD | 32.61% |
| 1996 | 23 Million USD | -16.06% |
| 1995 | 27.4 Million USD | 18.1% |
| 1994 | 23.2 Million USD | 118.87% |
| 1993 | 10.6 Million USD | -7.83% |
| 1992 | 11.5 Million USD | 309.09% |
| 1991 | -5.5 Million USD | -323.08% |
| 1990 | -1.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 3.49 Billion USD | 9.62% |
| 2024 Q1 | 2.59 Billion USD | -10.98% |
| 2024 Q2 | 2.94 Billion USD | 13.44% |
| 2023 Q3 | 3.15 Billion USD | 14.44% |
| 2023 Q4 | 2.91 Billion USD | -7.41% |
| 2023 FY | 11.3 Billion USD | 6.49% |
| 2023 Q1 | 2.7 Billion USD | -5.89% |
| 2023 Q2 | 2.75 Billion USD | 1.8% |
| 2022 Q2 | 2.56 Billion USD | -0.0% |
| 2022 Q4 | 2.87 Billion USD | 9.75% |
| 2022 FY | 10.61 Billion USD | -22.16% |
| 2022 Q1 | 2.56 Billion USD | -35.5% |
| 2022 Q3 | 2.61 Billion USD | 2.28% |
| 2021 FY | 13.63 Billion USD | 84.82% |
| 2021 Q2 | 4.44 Billion USD | 100.15% |
| 2021 Q1 | 2.22 Billion USD | 7.29% |
| 2021 Q4 | 3.96 Billion USD | 32.32% |
| 2021 Q3 | 2.99 Billion USD | -32.51% |
| 2020 FY | 7.37 Billion USD | 4.18% |
| 2020 Q4 | 2.06 Billion USD | 2.47% |
| 2020 Q3 | 2.02 Billion USD | 20.49% |
| 2020 Q2 | 1.67 Billion USD | 4.07% |
| 2020 Q1 | 1.61 Billion USD | -17.2% |
| 2019 Q4 | 1.94 Billion USD | 6.8% |
| 2019 FY | 7.08 Billion USD | 12.82% |
| 2019 Q1 | 1.53 Billion USD | -15.35% |
| 2019 Q2 | 1.78 Billion USD | 16.22% |
| 2019 Q3 | 1.82 Billion USD | 2.28% |
| 2018 Q3 | 1.55 Billion USD | 2.42% |
| 2018 Q2 | 1.51 Billion USD | 8.58% |
| 2018 Q1 | 1.39 Billion USD | -5.43% |
| 2018 FY | 6.27 Billion USD | 14.64% |
| 2018 Q4 | 1.81 Billion USD | 16.58% |
| 2017 Q3 | 1.39 Billion USD | 2.14% |
| 2017 FY | 5.47 Billion USD | 20.05% |
| 2017 Q4 | 1.47 Billion USD | 5.75% |
| 2017 Q1 | 1.23 Billion USD | 7.18% |
| 2017 Q2 | 1.36 Billion USD | 10.72% |
| 2016 Q2 | 1.14 Billion USD | 5.0% |
| 2016 Q3 | 1.17 Billion USD | 2.82% |
| 2016 FY | 4.56 Billion USD | 22.9% |
| 2016 Q1 | 1.08 Billion USD | 10.32% |
| 2016 Q4 | 1.15 Billion USD | -2.02% |
| 2015 Q3 | 1.02 Billion USD | 13.03% |
| 2015 FY | 3.71 Billion USD | 41.94% |
| 2015 Q2 | 909.77 Million USD | 15.8% |
| 2015 Q4 | 987.24 Million USD | -4.0% |
| 2015 Q1 | 785.65 Million USD | 5.76% |
| 2014 FY | 2.61 Billion USD | 34.12% |
| 2014 Q3 | 670.19 Million USD | 8.21% |
| 2014 Q2 | 619.32 Million USD | 6.38% |
| 2014 Q1 | 582.16 Million USD | 3.53% |
| 2014 Q4 | 742.85 Million USD | 10.84% |
| 2013 Q2 | 418.02 Million USD | 1.81% |
| 2013 Q3 | 558.45 Million USD | 33.59% |
| 2013 FY | 1.94 Billion USD | 50.65% |
| 2013 Q4 | 562.29 Million USD | 0.69% |
| 2013 Q1 | 410.6 Million USD | 6.81% |
| 2012 FY | 1.29 Billion USD | 193.03% |
| 2012 Q1 | 219.49 Million USD | 82.93% |
| 2012 Q2 | 282.55 Million USD | 28.73% |
| 2012 Q3 | 407.54 Million USD | 44.23% |
| 2012 Q4 | 384.43 Million USD | -5.67% |
| 2011 Q1 | 111.82 Million USD | -15.97% |
| 2011 FY | 441.6 Million USD | -3.36% |
| 2011 Q4 | 119.98 Million USD | 17.2% |
| 2011 Q3 | 102.38 Million USD | -4.68% |
| 2011 Q2 | 107.41 Million USD | -3.94% |
| 2010 Q3 | 105.6 Million USD | -8.55% |
| 2010 Q4 | 133.07 Million USD | 26.01% |
| 2010 FY | 456.98 Million USD | 21.03% |
| 2010 Q1 | 102.81 Million USD | 6.64% |
| 2010 Q2 | 115.48 Million USD | 12.32% |
| 2009 Q1 | 74.58 Million USD | 35.11% |
| 2009 Q2 | 89.59 Million USD | 20.12% |
| 2009 Q3 | 116.98 Million USD | 30.57% |
| 2009 Q4 | 96.41 Million USD | -17.58% |
| 2009 FY | 377.58 Million USD | 58.96% |
| 2008 Q3 | 65.29 Million USD | 7.66% |
| 2008 Q4 | 55.2 Million USD | -15.45% |
| 2008 FY | 237.53 Million USD | 89.99% |
| 2008 Q1 | 56.38 Million USD | -12.9% |
| 2008 Q2 | 60.64 Million USD | 7.56% |
| 2007 FY | 125.02 Million USD | 126.08% |
| 2007 Q4 | 64.73 Million USD | 190.13% |
| 2007 Q3 | 22.31 Million USD | 0.52% |
| 2007 Q2 | 22.19 Million USD | 40.58% |
| 2007 Q1 | 15.78 Million USD | 59.22% |
| 2006 Q3 | 12.57 Million USD | -23.58% |
| 2006 Q2 | 16.44 Million USD | 0.49% |
| 2006 Q1 | 16.36 Million USD | 7.12% |
| 2006 FY | 55.3 Million USD | -2.36% |
| 2006 Q4 | 9.91 Million USD | -21.11% |
| 2005 Q3 | 12.94 Million USD | -11.86% |
| 2005 Q1 | 13.71 Million USD | -68.55% |
| 2005 Q2 | 14.69 Million USD | 7.09% |
| 2005 FY | 56.63 Million USD | -64.34% |
| 2005 Q4 | 15.27 Million USD | 18.0% |
| 2004 Q3 | 27.53 Million USD | -1.28% |
| 2004 FY | 158.8 Million USD | 212.48% |
| 2004 Q1 | 59.76 Million USD | 193.47% |
| 2004 Q2 | 27.88 Million USD | -53.34% |
| 2004 Q4 | 43.61 Million USD | 58.41% |
| 2003 Q1 | 9.47 Million USD | 197.24% |
| 2003 FY | 50.82 Million USD | 227.77% |
| 2003 Q4 | 20.36 Million USD | 62.3% |
| 2003 Q3 | 12.54 Million USD | 22.15% |
| 2003 Q2 | 10.27 Million USD | 8.48% |
| 2002 Q1 | 3.68 Million USD | 13.68% |
| 2002 FY | 15.5 Million USD | 0.27% |
| 2002 Q2 | 3.7 Million USD | 0.71% |
| 2002 Q3 | 4.92 Million USD | 32.93% |
| 2002 Q4 | 3.18 Million USD | -35.36% |
| 2001 Q2 | 3.89 Million USD | -43.54% |
| 2001 FY | 15.46 Million USD | -64.62% |
| 2001 Q4 | 3.23 Million USD | -22.99% |
| 2001 Q3 | 4.2 Million USD | 8.01% |
| 2001 Q1 | 6.89 Million USD | -35.41% |
| 2000 FY | 43.71 Million USD | 41.46% |
| 2000 Q1 | 7.44 Million USD | -36.89% |
| 2000 Q2 | 13.19 Million USD | 77.13% |
| 2000 Q3 | 12.39 Million USD | -6.04% |
| 2000 Q4 | 10.67 Million USD | -13.85% |
| 1999 Q3 | 10.3 Million USD | 119.15% |
| 1999 Q4 | 11.8 Million USD | 14.56% |
| 1999 FY | 30.9 Million USD | -6.93% |
| 1999 Q1 | 4.2 Million USD | -27.59% |
| 1999 Q2 | 4.7 Million USD | 11.9% |
| 1998 Q3 | 9.5 Million USD | -22.76% |
| 1998 Q4 | 5.8 Million USD | -38.95% |
| 1998 FY | 33.2 Million USD | 8.85% |
| 1998 Q1 | 5.6 Million USD | -46.67% |
| 1998 Q2 | 12.3 Million USD | 119.64% |
| 1997 Q2 | 6.1 Million USD | 7.02% |
| 1997 FY | 30.5 Million USD | 32.61% |
| 1997 Q4 | 10.5 Million USD | 29.63% |
| 1997 Q3 | 8.1 Million USD | 32.79% |
| 1997 Q1 | 5.7 Million USD | -12.31% |
| 1996 FY | 23 Million USD | -16.06% |
| 1996 Q4 | 6.5 Million USD | 4.84% |
| 1996 Q3 | 6.2 Million USD | 0.0% |
| 1996 Q2 | 6.2 Million USD | 19.23% |
| 1996 Q1 | 5.2 Million USD | -10.34% |
| 1995 Q3 | 6.2 Million USD | -18.42% |
| 1995 Q4 | 5.8 Million USD | -6.45% |
| 1995 Q2 | 7.6 Million USD | 10.14% |
| 1995 Q1 | 6.9 Million USD | -10.39% |
| 1995 FY | 27.4 Million USD | 18.1% |
| 1994 Q4 | 7.7 Million USD | -13.48% |
| 1994 FY | 23.2 Million USD | 118.87% |
| 1994 Q1 | 3 Million USD | 3.45% |
| 1994 Q2 | 3.6 Million USD | 20.0% |
| 1994 Q3 | 8.9 Million USD | 147.22% |
| 1993 Q3 | -7 Million USD | -638.46% |
| 1993 Q2 | 1.3 Million USD | -38.1% |
| 1993 FY | 10.6 Million USD | -7.83% |
| 1993 Q1 | 2.1 Million USD | -8.7% |
| 1993 Q4 | 2.9 Million USD | 141.43% |
| 1992 Q1 | 3.5 Million USD | 216.67% |
| 1992 Q2 | 3.2 Million USD | -8.57% |
| 1992 Q3 | 2.4 Million USD | -25.0% |
| 1992 Q4 | 2.3 Million USD | -4.17% |
| 1992 FY | 11.5 Million USD | 309.09% |
| 1991 FY | -5.5 Million USD | -323.08% |
| 1991 Q4 | -3 Million USD | -500.0% |
| 1991 Q1 | 2 Million USD | 53.85% |
| 1991 Q3 | -500 Thousand USD | 58.33% |
| 1991 Q2 | -1.2 Million USD | -160.0% |
| 1990 Q3 | 1.3 Million USD | 8.33% |
| 1990 Q2 | 1.2 Million USD | 0.0% |
| 1990 Q1 | 1.2 Million USD | 0.0% |
| 1990 Q4 | 1.3 Million USD | 0.0% |
| 1990 FY | -1.3 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -9280.779% |
| Jaguar Health, Inc. | 7.72 Million USD | -146215.381% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 1702118.072% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 226028100.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -644.549% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -9337.258% |
| ContextLogic Inc. | 59 Million USD | -19054.915% |
| MiMedx Group, Inc. | 266.84 Million USD | -4135.224% |
| MEI Pharma, Inc. | 49.32 Million USD | -22811.185% |
| AlloVir, Inc. | -398 Thousand USD | 2839647.739% |
| Novavax, Inc. | 639.93 Million USD | -1666.018% |
| Aptorum Group Limited | -1.11 Million USD | 1013962.175% |
| Ardelyx, Inc. | 106.66 Million USD | -10495.625% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -4594.54% |
| Psyence Biomedical Ltd. | -240.00 USD | 4708916766.667% |
| Vaxcyte, Inc. | -75 Million USD | 15168.533% |
| Precigen, Inc. | 106 Thousand USD | -10661598.113% |
| Pharming Group N.V. | 220.1 Million USD | -5034.573% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -2194346.602% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -1119959.465% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -10195.339% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 6329.824% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 2187131.927% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 8825.602% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 25034.142% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 51500.373% |
| Acelyrin, Inc. | -115 Thousand USD | 9827404.348% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 1979329.422% |
| Senti Biosciences, Inc. | -2.68 Million USD | 421322.512% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -278878.03% |
| AbCellera Biologics Inc. | 38.02 Million USD | -29620.973% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 235643.977% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -9417733.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -38697.762% |
| Chimerix, Inc. | 324 Thousand USD | -3487986.42% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -2278408.065% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 13782295.122% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 36360.021% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 2297132.52% |
| Elevation Oncology, Inc. | -39 Thousand USD | 28978048.718% |
| Alkermes plc | 1.37 Billion USD | -722.112% |
| Fortress Biotech, Inc. | 57.85 Million USD | -19434.683% |
| Fortress Biotech, Inc. | 57.85 Million USD | -19434.683% |
| Agenus Inc. | 139.61 Million USD | -7994.689% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -68075.182% |
| Dyadic International, Inc. | 922.95 Thousand USD | -1224377.413% |
| ImmuCell Corporation | 4.39 Million USD | -256967.105% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -53560.32% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 10749.341% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 6463841.757% |
| Immix Biopharma, Inc. | -5468.00 USD | 206682616.459% |
| Incyte Corporation | 3.44 Billion USD | -228.467% |
| IO Biotech, Inc. | -756 Thousand USD | 1494994.18% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 24228.184% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 84704.945% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 25575821.915% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 11606.562% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 20548100.0% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -1409052.12% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 2144578.178% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -38357.141% |
| NextCure, Inc. | -3.68 Million USD | 306869.815% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -59246.742% |
| Onconetix, Inc. | -1.12 Million USD | 1002739.365% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 39113.394% |
| Opthea Limited | 21.72 Thousand USD | -52032128.361% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 19714365.778% |
| PureTech Health plc | -1.6 Million USD | 705115.596% |
| Pyxis Oncology, Inc. | -2 Million USD | 565170.0% |
| Seer, Inc. | 7.02 Million USD | -160728.234% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 112440653.179% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -143482.772% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 286788.544% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -2665324.528% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -10756.396% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -8254.76% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 11756.937% |
| ChromaDex Corporation | 50.78 Million USD | -22155.612% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 4871393.103% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 14664.035% |
| CRISPR Therapeutics AG | 240.95 Million USD | -4590.234% |
| Precision BioSciences, Inc. | 40.47 Million USD | -27823.997% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 11612.892% |
| Innoviva, Inc. | 261.06 Million USD | -4228.96% |
| Summit Therapeutics Inc. | -2.05 Million USD | 551387.805% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -258040.704% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -52354.862% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 9537870.801% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 7886576.717% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -1855630.706% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -3502.936% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -438959.829% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 22273257.272% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 159319.498% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 2381623.354% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 108667407.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -11613592.183% |
| Century Therapeutics, Inc. | -10.8 Million USD | 104655.463% |
| Kura Oncology, Inc. | -849 Thousand USD | 1331242.521% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 16941.619% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 7688127.211% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -11311.06% |
| Autolus Therapeutics plc | -4.86 Million USD | 232304.644% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -27207.302% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 6727123.81% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -11830.999% |
| GRI Bio, Inc. | 10.84 Million USD | -104146.841% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -444839.46% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 130195.545% |
| IGM Biosciences, Inc. | -211.66 Million USD | 5439.412% |
| INmune Bio, Inc. | 155 Thousand USD | -7291125.806% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -18146.016% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 750379.992% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 1742922.159% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 38605688.577% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -2811193.532% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 566302.405% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 3610770.927% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -11864.091% |
| Verastem, Inc. | -62 Thousand USD | 18228164.516% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -464023.203% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 4330138.314% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -373253.155% |
| Histogen Inc. | 3.76 Million USD | -299751.419% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -1961339.067% |
| Surrozen, Inc. | -27.23 Million USD | 41603.489% |
| Organovo Holdings, Inc. | -5.38 Million USD | 209812.377% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 938068.926% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 44165.193% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -56260.463% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 570777877.778% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -186194.296% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 16834945.302% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -7201.07% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -7751203.155% |
| Apollomics, Inc. | 127 Thousand USD | -8898640.157% |
| Amarin Corporation plc | 165.54 Million USD | -6726.949% |
| Mesoblast Limited | -9.81 Million USD | 115244.167% |
| Turnstone Biologics Corp. | 16.5 Million USD | -68368.436% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 10328.53% |
| Synaptogenix, Inc. | -6347.00 USD | 178059025.477% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 22159707.843% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -6903.625% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -542.98% |
| Better Therapeutics, Inc. | -2.72 Million USD | 414222.389% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 10176.051% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -3242.808% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 99065668.022% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 180633.546% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1020081.949% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -154332.884% |
| Insmed Incorporated | 239.63 Million USD | -4616.089% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -315758.021% |
| OmniAb, Inc. | 14.66 Million USD | -76953.249% |
| Alector, Inc. | -95.05 Million USD | 11989.577% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -8896.426% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 26102.347% |
| Zai Lab Limited | 170.9 Million USD | -6512.757% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -13702.899% |
| Aura Biosciences, Inc. | -1.29 Million USD | 872794.981% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -8693284.615% |
| Immunic, Inc. | -111 Thousand USD | 10181541.441% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -71184.218% |
| Veracyte, Inc. | 248.14 Million USD | -4454.298% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 261.702% |
| FibroGen, Inc. | 128.9 Million USD | -8667.3% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 2003794426.241% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 96967.33% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | -232.528% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -2905144.216% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -3080.402% |
| TG Therapeutics, Inc. | 219.1 Million USD | -5057.913% |
| Galecto, Inc. | -830 Thousand USD | 1361714.458% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 816085.56% |
| Fortrea Holdings Inc. | 424 Million USD | -2565.425% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 13215.694% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 1993292.24% |
| XBiotech Inc. | -1.74 Million USD | 648116.055% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1020081.949% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 24419.253% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 15062.004% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -15296.373% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -67158.228% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -2804.946% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 22863.51% |
| Vaxxinity, Inc. | -2.23 Million USD | 505981.826% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -3358.719% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 99901.816% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -46120.604% |
| NexImmune, Inc. | -1.02 Million USD | 1102705.73% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -209285085.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 159147.947% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 16911528.016% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 318359.645% |
| Ainos, Inc. | -253.73 Thousand USD | 4454152.094% |
| Pluri Inc. | 322 Thousand USD | -3509651.553% |
| Prothena Corporation plc | -129.2 Million USD | 8847.146% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -22312.766% |
| Celularity Inc. | 6.75 Million USD | -167204.219% |
| Rallybio Corporation | -150 Thousand USD | 7534366.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 34759.429% |
| MeiraGTx Holdings plc | 287 Thousand USD | -3937670.035% |
| Omeros Corporation | -69.77 Million USD | 16295.99% |
| Humacyte, Inc. | -76.55 Million USD | 14863.423% |
| Immunocore Holdings plc | 248.39 Million USD | -4449.843% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 74603.263% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -18016.444% |
| Blueprint Medicines Corporation | 236.58 Million USD | -4676.908% |
| CalciMedica, Inc. | -58 Thousand USD | 19485272.414% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 792624.544% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -38796.575% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 397476.934% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 36715.584% |
| Pulmatrix, Inc. | -8.22 Million USD | 137586.618% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 966031.624% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 2832531.078% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 2933.894% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -407071.821% |
| Cytokinetics, Incorporated | -322.59 Million USD | 3603.3% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -1310807.604% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 3314293.548% |
| Vor Biopharma Inc. | -3.49 Million USD | 323736.884% |
| Roivant Sciences Ltd. | 109.23 Million USD | -10245.951% |
| Evogene Ltd. | 1.39 Million USD | -807719.871% |
| ProKidney Corp. | -3.16 Million USD | 356723.541% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 25836.473% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -164715.517% |
| CorMedix Inc. | -205.56 Thousand USD | 5497906.015% |
| BioLineRx Ltd. | 1.1 Million USD | -1019881.949% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 14465.395% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 34246766.667% |
| Atai Life Sciences N.V. | -5000.00 USD | 226028100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 9274261.121% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 11772391.667% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 813735.709% |
| Sagimet Biosciences Inc. | 2 Million USD | -564970.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -1153451.324% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 13503.148% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 11952297.134% |
| GeoVax Labs, Inc. | -20.72 Million USD | 54641.42% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -4521.588% |
| Biomea Fusion, Inc. | -4.2 Million USD | 269116.901% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -1195.533% |
| Mereo BioPharma Group plc | 7.42 Million USD | -152086.911% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 3645712.903% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 94178433.333% |
| Absci Corporation | -41.84 Million USD | 27105.185% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 226028100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 14897.638% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 459319.829% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -5187.576% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 1201098.937% |
| Allakos Inc. | -6.14 Million USD | 184131.917% |
| Imunon, Inc. | -720 Thousand USD | 1569727.989% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 16479.79% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -2274.773% |
| BioAtla, Inc. | -103.73 Million USD | 10994.911% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 99065668.022% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 6349201.124% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 4754.249% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 3633990.675% |
| XOMA Corporation | 3.86 Million USD | -292606.553% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 16225.276% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -76291.78% |
| aTyr Pharma, Inc. | -2.38 Million USD | 473357.956% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -90601.445% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 38970444.828% |
| Viridian Therapeutics, Inc. | -1 Million USD | 1121270.635% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -86933846053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 282535100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -1674.461% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -5804181.283% |
| UroGen Pharma Ltd. | 73.35 Million USD | -15307.078% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 42436.855% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -97341846.598% |
| Orgenesis Inc. | -5.72 Million USD | 197504.367% |
| Entera Bio Ltd. | -56 Thousand USD | 20181171.429% |
| GH Research PLC | -315 Thousand USD | 3587846.032% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 5979676.72% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 2152747.619% |
| Xencor, Inc. | -85.26 Million USD | 13355.219% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 5114387.912% |
| Replimune Group, Inc. | -2.65 Million USD | 425764.783% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 1128844.871% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -6254.67% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -5804181.283% |
| Portage Biotech Inc. | -54 Thousand USD | 20928618.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 11952297.134% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 2997818.833% |
| OncoCyte Corporation | 413 Thousand USD | -2736316.465% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 251421679.533% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 5090720820.721% |
| Purple Biotech Ltd. | -196 Thousand USD | 5766120.408% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -125919.179% |
| scPharmaceuticals Inc. | 9.78 Million USD | -115432.611% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 108299.584% |
| HilleVax, Inc. | -2.15 Million USD | 524283.673% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 11651027.835% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 75322680.645% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 1691926.347% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 49136621.739% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 150561772.013% |
| Savara Inc. | -44.26 Million USD | 25632.963% |
| Curis, Inc. | 9.81 Million USD | -115091.112% |
| Daré Bioscience, Inc. | 2.76 Million USD | -407963.196% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 9056579.79% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 653737.941% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 4956854.386% |
| BeiGene, Ltd. | 2.07 Billion USD | -443.635% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 404313.312% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 2927.725% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -19836.142% |
| Erasca, Inc. | -3.73 Million USD | 302924.223% |
| bluebird bio, Inc. | -4.03 Million USD | 280531.762% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 40050422.489% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -493.445% |
| DBV Technologies S.A. | 15.72 Million USD | -71755.29% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 40050422.489% |
| Moderna, Inc. | 2.15 Billion USD | -424.427% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 1235225.683% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -141061.629% |
| Molecular Templates, Inc. | 50.39 Million USD | -22325.637% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 2108570.149% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -8347.245% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 181736.13% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 28825.313% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 10269.714% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 315077.703% |
| MacroGenics, Inc. | 50.52 Million USD | -22267.051% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 185429.616% |
| Prime Medicine, Inc. | -147.9 Million USD | 7740.986% |
| Aditxt, Inc. | -111.66 Thousand USD | 10121360.971% |
| Adagene Inc. | 18.11 Million USD | -62299.059% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -2315760.656% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -7960.798% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -7060.217% |
| SciSparc Ltd. | 2.19 Million USD | -514535.701% |
| Vericel Corporation | 135.57 Million USD | -8235.841% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 45117270.346% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 36477409.405% |
| Generation Bio Co. | -73.91 Million USD | 15390.552% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 2586232.723% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -20591.335% |
| Invivyd, Inc. | -2.02 Million USD | 557368.245% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 3856.602% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 10925871.96% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -11627.337% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -11398.25% |
| ADMA Biologics, Inc. | 88.21 Million USD | -12710.764% |
| Clene Inc. | 533 Thousand USD | -2120237.711% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -46775.913% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 1181019.54% |
| GeoVax Labs, Inc. | -20.72 Million USD | 54641.42% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -568380.885% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 5816090.449% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -22591.296% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 159454.202% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 1351942.105% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -13448.403% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -15457554.01% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -21158.418% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 6625.51% |
| Trevena, Inc. | 1.45 Million USD | -776628.522% |
| Surrozen, Inc. | -27.23 Million USD | 41603.489% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 3201629.745% |
| Cingulate Inc. | -582.91 Thousand USD | 1938863.257% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 36456229.032% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 57470.425% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 149292041.876% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 1282892.281% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -1560.247% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 1143966.397% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 20058670.871% |
| Kronos Bio, Inc. | 1.37 Million USD | -823617.201% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 21158.771% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 3870442.466% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 2314471.49% |
| ImmunityBio, Inc. | -17.89 Million USD | 63271.604% |
| Korro Bio, Inc. | -3.63 Million USD | 311433.333% |
| Kineta, Inc. | 5.43 Million USD | -207913.989% |
| BioVie Inc. | -229.37 Thousand USD | 4927097.912% |
| Codexis, Inc. | 57.33 Million USD | -19611.515% |
| Celularity Inc. | 6.75 Million USD | -167204.219% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -281519.736% |
| Celcuity Inc. | -142.77 Thousand USD | 7915797.756% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -22339097.47% |
| Cibus, Inc. | 1.42 Million USD | -794653.868% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 3021864.706% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 49410.179% |
| IN8bio, Inc. | -2.5 Million USD | 451975.25% |
| Kodiak Sciences Inc. | -25.94 Million USD | 43655.71% |
| Annexon, Inc. | -3.26 Million USD | 346025.926% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 553006.067% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 27177.653% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -1765743.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -1351.663% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -6434.301% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 594910.526% |
| Arcellx, Inc. | 108.27 Million USD | -10337.296% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 35014.27% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -14168.724% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 53529.463% |
| Moolec Science SA | -143.3 Thousand USD | 7886356.586% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 26805.893% |
| Geron Corporation | -123.5 Million USD | 9250.709% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -343721.113% |
| Royalty Pharma plc | 1.79 Billion USD | -529.991% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 16224.126% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 312884928.35% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -4884013.902% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 10243.609% |
| Humacyte, Inc. | -76.55 Million USD | 14863.423% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 1190756.297% |
| 89bio, Inc. | -273 Thousand USD | 4139806.96% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 899177.168% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 1332812.264% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 9188230.081% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -1009855.317% |
| Notable Labs, Ltd. | 113 Thousand USD | -10001138.938% |
| Liquidia Corporation | 14.6 Million USD | -77306.849% |
| Mustang Bio, Inc. | -2.22 Million USD | 508028.09% |
| Immunovant, Inc. | -231 Thousand USD | 4892480.952% |
| Quantum-Si incorporated | 488 Thousand USD | -2315760.656% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 20441.259% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 37671433.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -606849.517% |
| Acasti Pharma Inc. | -11 Thousand USD | 102740100.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 5523296.997% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 1742922.159% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 6846.621% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -995986.658% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 2966346.719% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 577291.011% |
| PepGen Inc. | -1.18 Million USD | 954610.135% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 8898840.157% |
| United Therapeutics Corporation | 2.07 Billion USD | -445.961% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 49457.558% |
| Solid Biosciences Inc. | -76.56 Million USD | 14860.916% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 13684998.829% |
| Immuneering Corporation | -764.13 Thousand USD | 1479073.693% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -17055012.882% |
| Belite Bio, Inc | -399 Thousand USD | 2832531.078% |
| XOMA Corporation | 3.86 Million USD | -292606.553% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 56505.47% |
| Bionomics Limited | -434.44 Thousand USD | 2601417.991% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1052371.881% |
| uniQure N.V. | 2.21 Million USD | -510121.219% |
| Cassava Sciences, Inc. | -89.42 Million USD | 12738.136% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 12374.924% |
| Forte Biosciences, Inc. | -9000.00 USD | 125571211.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 1353561.078% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 2586232.723% |
| Altimmune, Inc. | -65.37 Million USD | 17387.565% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -3021.675% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1052371.881% |
| Compugen Ltd. | 31.45 Million USD | -35828.787% |
| Peak Bio, Inc. | 367.76 Thousand USD | -3072861.56% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -45998.058% |
| Benitec Biopharma Inc. | 108 Thousand USD | -10464159.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 14489074.359% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 939534.746% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 620374.424% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 9497074.79% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 939534.746% |
| Instil Bio, Inc. | -4.75 Million USD | 237724.054% |
| argenx SE | 1.1 Billion USD | -919.539% |
| Immunome, Inc. | -8.9 Million USD | 126982.227% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 598057.672% |
| Verona Pharma plc | -679.62 Thousand USD | 1662990.069% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 6458042.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 473953.249% |
| CervoMed Inc. | -1.29 Million USD | 873721.222% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 469622.227% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 236679.443% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -457261.392% |
| Moolec Science SA | -143.3 Thousand USD | 7886356.586% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 2769847.323% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 423131.314% |
| AnaptysBio, Inc. | 14.78 Million USD | -76358.968% |
| Design Therapeutics, Inc. | -537 Thousand USD | 2104643.762% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 2646797.892% |
| NeurAxis, Inc. | 2.15 Million USD | -523912.567% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -526526.281% |
| Lumos Pharma, Inc. | 2 Million USD | -562999.153% |
| Achilles Therapeutics plc | -4.73 Million USD | 238966.249% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 6458042.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 10694587.816% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -35597.553% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -1310807.604% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 1095196.899% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 24912.066% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -26282225.581% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 1374966.18% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 85890052.88% |
| Palisade Bio, Inc. | 246 Thousand USD | -4593965.041% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 34246766.667% |
| Beam Therapeutics Inc. | -59.67 Million USD | 19039.201% |
| Neurogene Inc. | -3.26 Million USD | 346556.162% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -8010.956% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 306205.092% |
| Sesen Bio, Inc. | 40 Million USD | -28153.5% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 3805285.185% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 280738.097% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 118241.334% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -80165.625% |
| Athira Pharma, Inc. | -969 Thousand USD | 1166395.15% |
| Vaccinex, Inc. | -16 Million USD | 70716.096% |
| HCW Biologics Inc. | -574.82 Thousand USD | 1966162.656% |
| XOMA Corporation | 3.86 Million USD | -292606.553% |
| Nektar Therapeutics | 53.47 Million USD | -21032.802% |
| Arvinas, Inc. | 71.8 Million USD | -15640.111% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 13640.933% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 18103.027% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 3509851.553% |
| Rezolute, Inc. | -36 Thousand USD | 31392877.778% |
| Clene Inc. | 533 Thousand USD | -2120237.711% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 880171439.564% |
| BeyondSpring Inc. | 1.75 Million USD | -645325.471% |
| Synlogic, Inc. | -1.92 Million USD | 587490.852% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 30544424.324% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 178580.733% |
| Peak Bio, Inc. | 367.76 Thousand USD | -3072861.56% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 59697.11% |
| Krystal Biotech, Inc. | 47.6 Million USD | -23639.943% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -7910.008% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -224803.483% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 436579.108% |
| MannKind Corporation | 136.19 Million USD | -8198.199% |
| Ikena Oncology, Inc. | -50.49 Million USD | 22482.556% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -10285.98% |
| Gossamer Bio, Inc. | -4.38 Million USD | 257828.62% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 4484782.54% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 226028100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -7919.215% |
| Mural Oncology plc | -2.56 Million USD | 440357.109% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 2051170.78% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 11301500.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -54354.081% |
| REGENXBIO Inc. | 53.02 Million USD | -21211.735% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 211066.943% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 5874771.865% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 652605.774% |
| Vaxart, Inc. | -60.76 Million USD | 18699.148% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 4300807.816% |
| Cellectis S.A. | 18 Thousand USD | -62785455.556% |
| Longeveron Inc. | 221 Thousand USD | -5113655.656% |
| Repare Therapeutics Inc. | -80.07 Million USD | 14214.4% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -933.986% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 873469.397% |
| Revolution Medicines, Inc. | -399.66 Million USD | 2927.725% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 32289814.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -23063981.633% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | -31.305% |
| Denali Therapeutics Inc. | -93.34 Million USD | 12207.129% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 45117270.346% |
| Veru Inc. | 7.56 Million USD | -149272.291% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 7484470.861% |
| Cingulate Inc. | -582.91 Thousand USD | 1938863.257% |
| Passage Bio, Inc. | -3.72 Million USD | 303819.43% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 93834374.327% |
| Exicure, Inc. | -1.42 Million USD | 794295.362% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 2950857.18% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -418005.808% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 2204498.498% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -16488.968% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 7554158.299% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 19188.268% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -2890283.632% |
| OmniAb, Inc. | 14.66 Million USD | -76953.249% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -56426.784% |
| Lipocine Inc. | -2.85 Million USD | 396526.569% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 613306.728% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 198196.407% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 750379.992% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -14905.311% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 17386869.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -13306.805% |
| Ocugen, Inc. | -33.53 Million USD | 33798.303% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 357513.03% |
| Q32 Bio Inc. | 578 Thousand USD | -1955159.516% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 4264779.245% |
| Alumis Inc. Common Stock | -1.28 Million USD | 880271.34% |
| Equillium, Inc. | 35.95 Million USD | -31329.445% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 662162.097% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -2257114.702% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 273376974.698% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 4363574.903% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -2673446.055% |
| Dominari Holdings Inc. | 2.03 Million USD | -554161.893% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 6159874.569% |
| vTv Therapeutics Inc. | -13.59 Million USD | 83229.092% |
| Bio-Techne Corporation | 773.07 Million USD | -1361.878% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -65154.345% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -2352.635% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 966857.913% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 47228.44% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -96517.936% |
| Nkarta, Inc. | -5.86 Million USD | 192660.913% |
| BioCardia, Inc. | -7.24 Million USD | 156002.883% |
| Iterum Therapeutics plc | -1.75 Million USD | 645894.286% |